Roger M. Phillips

发表

Mathematical and computational models of drug transport in tumours

R M Phillips, S W Smye, B D Sleeman, 2014, Journal of The Royal Society Interface.

Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors

S. Allison, M. Ahmadi, R. Phillips, 2014, British journal of pharmacology.

5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro.

G. Adams, I. Stratford, M. Jaffar, 1998, Anti-cancer drug design.

Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.

D. Ross, D. Siegel, N. Gibson, 1994, Oncology research.

Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents.

S. Croft, J. Brown, P. Pollet, 2001, Journal of medicinal chemistry.

Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.

P. Loadman, H. Fiebig, C. Jarrett, 2000, Cancer research.

Identification of differentially expressed genes in experimental models of the tumor microenvironment using differential display.

R. Phillips, H. J. Knowles, Roger M. Phillips, 2001, Anticancer research.

A mathematical model of doxorubicin penetration through multicellular layers.

S W Smye, P M Loadman, B. Sleeman, 2009, Journal of theoretical biology.

Avascular tumour growth dynamics and the constraints of protein binding for drug transportation.

N. Kazmi, Mohammed Alamgir Hossain, Roger M. Phillips, 2012, Journal of theoretical biology.

Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids.

A. Scally, L. Patterson, C. Sutton, 2012, Journal of proteome research.